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Abstract
Background: Vestibular disease (VD), central or peripheral, can be a dramatic
primary-care presentation. Current literature describes mostly dogs examined in
referral centers.
Hypothesis/Objectives: Describe the prevalence, presentation, clinical management,
and outcomes of VD in dogs under primary veterinary care at UK practices participat-
ing in VetCompass.
Animals: Seven hundred and fifty-nine vestibular cases identified out of 905 544
study dogs.
Methods: Retrospective cohort study. Potential VD cases clinically examined during
2016 were verified by reviewing clinical records for signalment, presenting clinical
signs, treatments, and outcomes. Multivariable logistic regression was used to evalu-
ate factors associated with VD.
Results: The overall prevalence of VD was 8 per 10 000 dogs (95% CI = 7-9). Median
age at first diagnosis was 12.68 years (interquartile range [IQR], 11.28-14.64). Com-
pared with crossbreeds, breeds with the highest odds of VD diagnosis included French
Bulldogs (odds ratio [OR] = 9.25, 95% CI = 4.81-17.76, P < .001), Bulldogs (OR = 6.53,
95% CI = 2.66-16.15, P < .001), King Charles Spaniels (OR = 4.96, 95% CI = 2.52-9.78,
P < .001), Cavalier King Charles Spaniels (OR = 3.56, 95% CI = 2.50-5.06, P < .001), and
Springer Spaniels (OR = 3.37, 95% CI = 2.52-4.52, P < .001). The most common pre-
senting signs were head tilt (69.8%), nystagmus (68.1%), and ataxia (64.5%). The most
frequently used treatments were antiemetics (43.2%), systemic glucocorticoids (33.1%),
antimicrobials (25%), and propentofylline (23.25%). There were 3.6% of cases referred.
Improvement was recorded in 41.8% cases after a median of 4 days (IQR, 2-10.25).
Conclusions: Our study identifies strong breed predispositions for VD. The low refer-
ral rates suggest that primary-care data sources offer more generalizable information
for benchmarking to help clinicians review their own clinical activities.
Abbreviations: CKCS, Cavalier King Charles Spaniel; CN, cranial nerve; EPR, electronic patient record; IMHA, immune mediated hemolytic anemia; IPVD, idiopathic peripheral vestibular disease;
IQR, interquartile range; MUO, meningoencephalitis of unknown origin; OR, odds ratio; VD, vestibular disease.
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1 | INTRODUCTION
Vestibular disease (VD) is characterized by a dysfunction of the parts
of the nervous system responsible for the maintenance of equilibrium
and balance.1 The diagnosis of VD is based on cardinal neurological
examination abnormalities such as ataxia, head tilt, and pathological
nystagmus and strabismus. These characteristic clinical signs can be
caused by either central or peripheral neurological dysfunction.2 Neu-
rological signs associated with central involvement include proprio-
ception deficits, altered mentation, cranial nerve (CN) deficits other
than CN VII or VIII, and vertical or dysconjugate nystagmus. Recogni-
tion of these clinical signs can help the clinician differentiate between
central and peripheral variants and has an important role in decision
making regarding clinical management and when considering referral
for advanced imaging. The most common diagnoses in dogs pre-
senting with peripheral VD are otitis media/interna and idiopathic
peripheral VD (IPVD).2 IPVD is reportedly more common in older dogs
and the diagnosis is made by exclusion.1 For central VD, multiple cau-
ses are reported, including anomalous, metabolic, neoplastic, infec-
tious/inflammatory, traumatic, toxic, and vascular etiologies.3
Regardless of the etiology, VD can be a serious welfare concern
for affected dogs. Clinical signs are often dramatic on presentation,4
with severe disorientation causing distress for both the affected ani-
mal and the owner. Although vestibular disorders in dogs are report-
edly common,5-7 there is limited information on the prevalence, risk
factors, progression, and outcome of VD in the primary-care popula-
tion of dogs because the current veterinary literature is based mainly
on the subset of cases presenting to referral institutes. These referral
cases are likely to be more complex cases with more financially com-
mitted owners and therefore to generalize poorly to the wider
population.8
The current study aimed to describe the signalment, prevalence,
and risk factors in dogs diagnosed with VD in primary-care practice in
the United Kingdom and to describe disease progression, clinical man-
agement, and outcomes of these cases.
2 | MATERIALS AND METHODS
The VetCompass Programme collates de-identified electronic patient
record (EPR) data from primary-care veterinary practices in the
United Kingdom for epidemiological research.9 VetCompass collects
information fields that include species, breed, date of birth, sex, neu-
ter status and bodyweight, and clinical information from free-form
text clinical notes and summary diagnosis terms (VeNom codes10) plus
treatment and deceased status with relevant dates. The EPR data
were extracted from practice management systems using integrated
clinical queries and uploaded to a secure VetCompass structured
query language database.11
A retrospective cohort study design of dogs attending
VetCompass practices was used to estimate the 1 year (2016) period
prevalence, risk factors, and clinical management for VD. The sam-
pling frame for the current study included dogs under veterinary care
within the VetCompass database for a 1-year period from 1 January
2016 to 31 December 2016. Dogs “under veterinary care” were
defined as those with either at least 1 EPR recorded from 1 January
2016 to 31 December 2016 or, alternatively, at least 1 EPR during
both 2015 and 2017. Ethical approval was granted by the RVC Ethics
and Welfare Committee (reference number URN 2015 1369).
Case inclusion criteria required that a final diagnosis of VD or a
synonym (eg, vestibular attack, geriatric vestibular syndrome, canine idi-
opathic vestibular syndrome, old-dog vestibular disease) was recorded in
the EPR for a condition that was present during the 2016 study
period. Case-finding involved initial screening of all EPRs for candi-
date VD cases by searching the clinical free-text field and VeNom
term field using the search terms nyst* and vest*.
The candidate cases were randomly ordered, and the clinical
notes of all candidate animals were manually reviewed in detail to
evaluate for case inclusion. All dogs from the overall study denomina-
tor that were not confirmed as VD cases were included as noncases in
the risk factor analysis. The full clinical notes for each confirmed ves-
tibular case dog were manually reviewed to extract data on additional
study questions of interest related to the VD: date of first diagnosis,
clinical signs on first presentation, clinical management and treat-
ments prescribed, referral, clinical improvement, and death. Options
for clinical signs at presentation included the presence, absence or
unrecorded status for ataxia, nystagmus, head tilt, collapse, vomiting,
otitis externa, and central involvement (defined as 1 or more of the
following: proprioceptive deficits, altered mentation, CN deficits other
than VII or VIII, and a vertical, positional or dysconjugate nystagmus).
Improvement was defined as evidence of clinical improvement and
absence of ataxia and nystagmus recorded in the EPR although these
dogs might still have shown a residual head tilt.
A purebred variable categorized all dogs of recognizable breeds as
“purebred” and the remaining dogs as “crossbred.”12 A breed variable
included individual breeds represented by 5 or more VD cases, a
grouped category of all remaining purebreds and a general grouping
of crossbred dogs. This approach was taken to facilitate statistical
power for the individual breed analyses.13 Spaniel-type breeds
included the following breeds that had the word “spaniel” in their
name: American Cocker, Brittany, Cavalier King Charles, Clumber,
English Cocker, English Springer, English Toy, Field, Japanese (also
known as Japanese Chin), King Charles, Picardy, Sussex, Tibetan,
Welsh Cocker, Working Cocker, Water Spaniel, and Welsh Springer.
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Brachycephalic-type breeds included breeds known to have brachyce-
phalic characteristics.14
Sex (female, male, unrecorded) and neuter (neutered, entire,
unrecorded) variables described the status recorded at the final EPR.
Age (years) was calculated for all dogs at the final date of the study
period (31 December 2016). An age variable categorized age (years)
into 6 groups (<3.0, 3.0 to <6.0, 6.0 to <9.0, 9.0 to<12.0, ≥12.0 and
unknown). Adult bodyweight described the maximum bodyweight (kg)
recorded for dogs >18 months. An adult bodyweight variable catego-
rized adult bodyweight into 5 groups (<10.0, 10.0 to <25, 25 to <40,
≥40.0 and unknown).
With the aim of reducing errors such as spelling mistakes or miss-
ing/inappropriately collected data, checking and cleaning of the data
was performed in Excel (Microsoft Office Excel 2016, Microsoft
Corp.). Statistical analyses were conducted using IBIM SPSS Version
26. The 1-year period prevalence with 95% confidence intervals
(CI) described the probability of having a new or ongoing diagnosis of
VD at any time during the 1-year 2016 study period. The 1-year inci-
dence risk with 95% CI described the probability of having a new
diagnosis of VD at any time during the 1-year 2016 study period.
Descriptive statistics characterized the risk factors separately for the
case and noncase dogs.
Binary logistic regression modeling was used to evaluate
univariable associations between risk factors (breed, purebred, spaniel
type, brachycephalic type, adult bodyweight, age, sex, neuter) and having
a diagnosis of VD during 2016. Because breed was a factor of primary
interest for the study, purebred, spaniel type, brachycephalic type, and
adult bodyweight (a defining characteristic of individual breeds) were
excluded from the initial breed multivariable modeling. Instead, each
of these variables individually replaced the breed variable in the main
final breed model in order to evaluate their effects after taking
account of the other variables. In line with common practice in multi-
variable model building, risk factors with liberal associations in
univariable modeling (P < .2) were taken forward for multivariable
evaluation.15 Model development used manual backwards stepwise
elimination. Pair-wise interaction effects were evaluated for the final
model variables. For the final model, the area under the receiver oper-
ating characteristic (ROC) curve was used to evaluate the quality of
the model fit.15,16 Statistical significance was set at P < .05.
3 | RESULTS
The overall study population comprised 905 544 dogs under primary
veterinary care at 886 veterinary clinics during 2016. Of 2600 dogs
identified as candidate VD cases, manual checking identified 759 con-
firmed VD cases, giving an overall prevalence of 8 per 10 000 dogs
(95% CI = 7-9 per 10 000 dogs). The prevalence in dogs that were
9 years or older (636/177 754) was 36 per 10 000 dogs (95% CI = 33-
39) and the prevalence for each breed is shown in Table 1. Out of the
759 VD cases, only 39 (5.13%) were pre-existing cases that were diag-
nosed with VD before 2016, therefore the incidence of VD was simi-
lar to the prevalence: 8 per 10 000 dogs (95% CI = 7-9).
Of the VD cases with demographic data available, 586 (77.21%)
were purebred, 381 (50.19%) were female, and 538 (70.88%) were
neutered. Dogs with VD had a median adult bodyweight of 18.61 kg
(interquartile range [IQR], 11.28-26.20; range, 1.71-79.67) and a
median age at diagnosis of 12.68 years (IQR, 11.28-14.64; range,
0.43-20.7). The most common breeds among the VD cases and
noncases are shown in Table 2.
Of the noncase dogs with complete data available, 654 813
(72.31%) were purebred, 431 328 (47.63%) were female, and
407 427 (44.99%) were neutered. The median adult bodyweight for
noncases was 16.94 kg (IQR, 9.08-22.10; range, 1.37-79). Data com-
pleteness across the variables assessed was breed 99.91%, age
98.62%, sex 99.53%, neuter status 99.53%, and adult
bodyweight 65.68%.
Univariable logistic regression modeling identified 4 variables that
were liberally associated with VD and were further evaluated in the
breed multivariable logistic regression modeling: breed, adult
bodyweight, purebred status, and age. Sex and neuter status were not
associated with the odds of VD in univariable analysis.
The final breed multivariable model retained 2 variables: breed
and age. Compared with crossbred dogs, 11 breeds showed increased
odds of VD after accounting for the confounding effect of age. The
final model showed acceptable discrimination (area under the ROC
curve: 0.662). The breeds with the highest odds included the French
Bulldog (odds ratio [OR] = 9.25, 95% CI = 4.81-17.76, P < .001), Bull-
dog (OR = 6.56, 95% CI = 2.66-16.15, P < .001), King Charles Spaniel
(OR = 4.96, 95% CI = 2.52-9.78, P < .001), Cavalier King Charles Span-
iel (CKCS) (OR = 3.56, 95% CI = 2.50-5.06, P < .001), Springer Spaniel
(OR = 3.37, 95% CI = 2.52-4.52, P < .001), Boxer (OR = 2.68, 95%
CI = 1.57-4.56, P < .001), and Golden Retriever (OR = 2.55, 95%
CI = 1.69-3.84, P < .001) (Table 3).
The odds of VD increased significantly with age; dogs over
12 years of age had 327.71 times the odds (95% CI = 171.73-625.38)
and dogs between 9 and 12 years of age had 38.82 times the odds
(95% CI = 19.93-75.59 of VD compared to dogs under 3 years of
age). The breeds that were less likely to be diagnosed with VD were
West Highland White Terrier (OR = 0.58, 95% CI = 0.35-0.96,
P = .04), Jack Russell Terrier (OR = 0.56, 95% CI = 0.38-0.81,
P = .003), and Yorkshire Terrier (OR = 0.39, 95% CI = 0.21-
0.70, P = .002).
Spaniel type breeds were strongly associated with VD, showing
1.98 times the odds (95% CI = 1.61-2.43, P < .001) compared with
nonspaniel type breeds. Brachycephalic type breeds had 1.29 times
the odds of VD compared with nonbrachycephalic type breeds (95%
CI = 1.02-1.63, P = .03).
Dogs with an adult bodyweight under 10 kg were significantly
less likely to be diagnosed with VD when compared to all other
bodyweight categories.
The most common presenting signs recorded for VD cases were
head tilt (530/759, 69.82%), nystagmus (516/759, 67.98%), and ataxia
(489/759, 64.42%) (Table 4). The direction of nystagmus was
recorded in 371/516 (71.89%) cases, with most cases reported to
have a horizontal nystagmus (304/516, 58.91%), out of which 70/304
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(23.02%) cases had a horizontal nystagmus with the fast phase to the
left, 67/304 (22.03%) had a fast phase to the right, and 167/304
(54.93%) were recorded as horizontal only. A vertical nystagmus was
noted in 38/516 (7.36%) cases, a rotary nystagmus in 28/516 (5.42%)
cases and 1 case had a description consistent with dysconjugate nys-
tagmus (each eye moving in a different direction).
Of 530 dogs that presented with a head tilt, 232 (43.77%) had a
left sided head tilt, 208 (39.24%) had a right sided head tilt, and in
90 (16.98%) cases the head tilt direction was not recorded. From the
cases where both the direction of the horizontal nystagmus and the
head tilt were recorded, 66/168 (39.28%) had a left sided head tilt
with a horizontal nystagmus with a fast phase to the right side, and
102/168 (60.71%) had a right sided head tilt with a horizontal nystag-
mus with a fast phase to the left side.
Out of the 759 cases diagnosed with VD, 139 (18.31%) were hos-
pitalized for management and the treatments prescribed are summa-
rized in Table 5.
There were 27/759 (3.55%) cases referred. A specific cause of
VD in the clinical notes or in a referral letter was recorded in 33/759
(4.34%) of the cases. Out of these, 14 were recorded with IPVD,
11 with brain disease, 7 with either otitis media or interna, and 1 case
with metronidazole toxicity. Of the 14 cases diagnosed with IPVD,
3/14 (21.42%) were reported to have facial nerve palsy.
Of the 11 cases with a brain disease confirmed, 6 were diagnosed
with meningoencephalitis of unknown origin (MUO), 2 with intracra-
nial neoplasia, 1 with Chiari-like malformation, 1 with rostral cerebel-
lar ischemic stroke (suspected to be caused by thromboembolic
disease), and 1 with an unspecified cerebellar lesion.
TABLE 1 Prevalence of vestibular disease in dogs in the VetCompass database under primary veterinary care in the United Kingdom from 1
January 2016 to 31 December 2016
Cases
Denominator (all dogs under
primary veterinary care)
Prevalence
(nr per 10 000 dogs)
95% Confidence
interval
Overall 759 905 544 8 7-9
Age (y)
0 to <3 13 329 266 0
3 to <9 101 385 353 3 2-4
9 to <12 110 108 475 10 8-12
>12 526 692 279 8 7-9
Unavailable 9 12 411 7 2-12
Breed
King Charles Spaniel 9 2804 32 11-53
Springer Spaniel 63 20 145 31 23-39
Golden Retriever 27 9766 28 18-38
Cavalier King Charles Spaniel 39 17 219 23 16-30
Border Collie 52 22 352 23 17-29
Boxer 15 9427 16 8-24
Bulldog 5 3228 15 2-28
Miniature Schnauzer 11 8385 13 5-21
Labrador Retriever 70 59 893 12 9-15
Beagle 8 8062 10 3-17
West Highland White Terrier 17 18 861 9 5-13
German Shepherd Dog 19 21 321 9 5-13
Cocker Spaniel 28 32 117 9 6-12
Border Terrier 9 9642 9 3-15
Crossbreed 168 199 798 8 7-9
French Bulldog 11 16 386 7 3-11
Staffordshire Bull Terrier 38 53 017 7 5-9
Jack Russell Terrier 33 48 402 7 5-9
Yorkshire Terrier 12 28 168 4 2-6
Shih-Tzu 12 32 898 4 2-6
Other purebreds 113 282 894 4 3-5
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TABLE 2 Descriptive and univariable logistic regression results in dogs with vestibular disease in the VetCompass database under primary
veterinary care in the United Kingdom from 1 January 2016 to 31 December 2016
Variable Category Case no. (%) Noncase no. (%)
Odds
ratio 95% CI P value
Purebred status Crossbred 170 (22.40) 245 805 (27.14) Base
Purebred 586 (77.21) 654 813 (72.31) 1.29 1.09-1.53 .003
Spaniel type breeds Nonspaniel type 446 (58.76) 530 052 (58.53) Base
Spaniel-type 148 (19.50) 76 784 (8.48) 1.16 0.78-1.73 .46
Unknown 165 (21.74) 197 949 (21.86) 1.16 0.78-1.73 .46
Brachycephalic type breeds Nonbrachycephalic 483 (63.64) 526 605 (58.15) Base
Brachycephalic 110 (14.49) 166 793 (18.42) 0.63 0.44-0.92 .02
Unknown 165
(21.74%)
197 949
(21.86%)
1.11 0.49-2.49 .79
Common breeds Crossbreed 168 (22.13) 193 798 (21.40) Base
King Charles Spaniel 9 (1.19) 2804 (0.31) 3.81 1.95-7.47 <.001
Springer Spaniel 63 (8.30) 20 145 (2.22) 3.71 2.78-4.97 <.001
Golden Retriever 27 (3.56) 9766 (1.08) 3.28 2.18-4.93 <.001
Border Collie 52 (6.85) 22 352 (2.47) 2.76 2.02-3.77 <.001
Cavalier King Charles
Spaniel
39 (5.14) 17 219 (1.9) 2.69 1.90-3.81 <.001
Boxer 15 (1.98) 9427 (1.04) 1.89 1.11-3.21 .02
Bulldog 5 (0.66) 3228 (0.36) 1.84 0.75-4.48 .18
Miniature Schnauzer 11 (1.45) 8385 (0.93) 1.56 0.84-2.87 .15
Labrador Retriever 70 (9.22) 59 893 (6.61) 1.39 1.05-1.83 .02
Beagle 8 (1.05) 8062 (0.89) 1.18 0.58-2.39 .65
Border Terrier 9 (1.19) 9642 (1.06) 1.11 0.56-2.17 .76
West Highland White
Terrier
17 (2.24) 18 861 (2.08) 1.07 0.65-1.76 .79
German Shepherd Dog 19 (2.50) 21 321 (2.35) 1.06 0.65-1.70 .81
Cocker Spaniel 28 (3.69) 32 117 (3.55) 1.03 0.69-1.54 .86
Staffordshire Bull Terrier 38 (5.01) 53 017 (5.85) 0.85 0.59-1.21 .37
Jack Russell Terrier 33 (4.35) 48 402 (5.35) 0.81 0.55-1.17 .27
French Bulldog 11 (1.45) 16 386 (1.81) 0.78 0.43-1.47 .47
Yorkshire Terrier 12 (1.58) 28 168 (3.11) 0.50 0.28-0.91 .02
Other purebreds 113 (14.89( 282 894 (31.24) 0.47 0.37-0.60 <.001
Shih-Tzu 12 (1.58) 32 898 (3.63) 0.43 0.24-0.77 .005
Adult (over 18 mo.) bodyweight
(kg)
0 to <10 98 (12.91) 213 352 (23.56) Base
10 to <25 303 (39.92) 231 667 (25.58) 1.72 1.33-2.22 <.001
25 to <40 131 (17.26) 123 724 (13.66) 1.33 0.98-1.81 .64
≥40 19 (2.50) 26 257 (2.90) 1.39 0.82-2.35 .21
Unknown 208 (27.40) 310 542 (34.29) 1.66 1.28-2.16 <.001
Age category (y) 0 to <3 13 (1.71) 329 266 (36.36) Base
3 to <6 36 (4.74) 222 304 (24.54) 4.14 2.01-8.53 <.001
6 to <9 65 (8.56) 163 049 (18.00) 12.67 6.49-24.71 <.001
9 to <12 110 (14.49) 108 475 (11.97) 32.93 17.22-62.94 <.001
≥12 526 (69.30) 692 279 (76.45) 255.92 136.90-478.40 <.001
Unknown 9 (1.18) 12 411 (1.37) 17.46 7.35-41.46 <.001
Sex Female 381 (50.20) 431 328 (47.63) Base
Male 372 (49.01) 469 233 (51.82) 0.97 0.84-1.12 .69
Unknown 6 (0.79) 4222 (0.47) 0 0-0 1.000
(Continues)
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Out of the 7 cases that were diagnosed with otitis media or
interna, 1 case was reported to have Horner's syndrome, and another
had Horner's syndrome with facial nerve palsy.
Clinical improvement was recorded in 317/759 (41.76%) of the
cases after a median 4 days (IQR, 2-10.25; range, 0-160 days) from
the first diagnosis. In 310/759 (40.84%) of the cases, there was no
mention of improvement or deterioration because of the loss of com-
plete follow-up for VD. A persistent head tilt (defined as head tilt
recorded in the EPR after more than 1 month from improvement) was
recorded in 68 (8.95%) of the cases and recurrence of VD was
recorded in 78 (10.27%) of the cases.
Of 232/759 (30.56%) deaths during the study period, there was
evidence in the EPRs that VD contributed to the death or the decision
to euthanize in 144/232 (62.06%) of the deaths and 144/759
(18.97%) of the total cases. Out of these, 88/759 (11.59%) were
euthanized on first veterinary presentation with VD.
TABLE 2 (Continued)
Variable Category Case no. (%) Noncase no. (%)
Odds
ratio 95% CI P value
Neuter status Entire 215 (38.33) 493 196 (54.46) Base
Neutered 538 (70.88) 407 427 (44.99) 1.54 1.31-1.81 .33
Unknown 6 (0.79) 4222 (0.47) 0 0-0 1.000
TABLE 3 Final multivariable logistic regression results in dogs with VD in the VetCompass database under primary veterinary care in the
United Kingdom from 1 January 2016 to 31 December 2016
Variable Category Odds ratio 95% CI P value Median age (y) (range)
Common breeds Crossbreed Base 13.67 (2.75-17.83)
French Bulldog 9.25 4.81-17.76 <.001 5.66 (1.06-18.14)
Bulldog 6.56 2.66-16.15 <.001 4.42 (1.99-9.46)
King Charles Spaniel 4.96 2.52-9.78 <.001 10.76 (5.10-14.67)
Cavalier King Charles Spaniel 3.56 2.50-5.06 <.001 8.83 (2.61-14.36)
Springer Spaniel 3.37 2.52-4.52 <.001 13.67 (4.46-15.78)
Boxer 2.68 1.57-4.56 <.001 9.75 (6.07-16.55)
Golden Retriever 2.55 1.69-3.84 <.001 14.10 (3.85-15.41)
Beagle 2.52 1.23-5.14 .01 10.40 (6.84-14.25)
Miniature Schnauzer 2.34 1.26-4.33 .007 13.62 (3.01-15.60)
Border Collie 2.16 1.58-2.96 <.001 14.06 (11.43-16.58)
German Shepherd Dog 1.52 0.94-2.45 .08 12.43 (5.83-16.91)
Labrador Retriever 1.36 1.03-1.81 .03 13.63 (1.00-17.16)
Cocker Spaniel 1.32 0.88-1.97 .17 13.58 (2.59-17.67)
Border Terrier 0.99 0.50-1.94 .98 13.81 (10.97-16.03)
Other purebreds 0.81 0.63-1.03 .09 12.60 (0.43-18.45)
Staffordshire Bull Terrier 0.78 0.55-1.12 .19 14.12 (5.45-20.07)
Shih-Tzu 0.71 0.39-1.28 .26 12.69 (1.73-17.07)
West Highland White Terrier 0.58 0.35-0.96 .04 13.91 (1.02-17.99)
Jack Russell Terrier 0.56 0.38-0.81 .003 14.60 (3.36-29.24)
Yorkshire Terrier 0.39 0.21-0.70 .002 12.62 (5.97-17.21)
Age category (y) 0 to <3 Base
≥12 327.71 171.73-625.38 <.001
9 to <12 38.82 19.93-75.59 <.001
Unknown 24.76 10.05-60.93 <.001
6 to <9 14.88 7.51-29.49 <.001
3 to <6 7.63 2.28-9.80 <.001
Abbreviation: VD, vestibular disease.
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4 | DISCUSSION
This is the largest study to explore the wider presentation of VD in
dogs attending primary-care practices by analyzing clinical data from a
multicenter primary-care research database. Previous studies of
VD5,7,17-19 have relied mainly on referral populations and therefore
might be poorly representative of the general population. The overall
prevalence of VD in the current study was 8 per 10 000 dogs, but the
prevalence in dogs aged 9 years or older was significantly higher at
36 per 10 000 dogs.
French Bulldogs and Bulldogs had the highest odds of diagnosis
with VD compared to crossbreed dogs: 9.25 and 6.56 times, respec-
tively. French bulldogs have previously been reported as more fre-
quently affected by VD compared to other breeds.5 In a
United Kingdom-based referral population of French Bulldogs that
presented with neurological disorders, 16/343 were diagnosed with
peripheral VD and 25/343 were diagnosed with brain neoplasia.20
Brachycephalic breeds are reported to have a higher incidence of glio-
mas that can cause vestibular signs.21 MUO and otitis media and/or
interna are also common in French Bulldogs and these conditions can
present showing vestibular signs.20 These findings add to the already
known disease burden22-28 for French Bulldogs and Bulldogs and have
important welfare implications, as VD can cause disorientation, loss of
balance, and even pain in cases of otitis media/interna. A previous
study of the overall disorders in French Bulldogs under primary care
in the United Kingdom reported “brain disorder” as the most common
cause of mortality.26 It is interesting to note that both French Bulldogs
and Bulldogs did not show significantly increased odds for being
diagnosed with VD in the univariable logistic regression analysis
(Table 2). We believe that, in the univariable model, the age was a
confounding factor. Both breeds had a lower median age at presenta-
tion (Table 3), which could suggest that diseases associated with older
age (such as IPVD or neoplastic diseases) were less likely to be the
cause for VD in these breeds.
King Charles Spaniels and CKCS were also shown to have
increased odds of VD compared with crossbred dogs, 4.96 and 3.56
times, respectively. A previous study on the disorders causing presenta-
tion to primary care practice in CKCS found a prevalence of neurologi-
cal causes to be 4.3%.29 CKCS are known to be predisposed to
several neurological syndromes that can cause vestibular signs,
including occipital hypoplasia/syringomyelia, granulomatous
meningoencephalomyelitis (GME), and VD.30 Moreover, CKCS have a
tendency toward cerebrovascular disease, particularly rostral cerebellar
artery infarction.31-33 In immature dogs, the first presenting sign of
syringomyelia could be scoliosis, which can appear similar to a head tilt
of vestibular origin.30 VD in CKCS can be also idiopathic—CKCS is one
of the most commonly seen breeds with idiopathic facial nerve paraly-
sis34 and facial and vestibular neuropathy of unknown origin.35 Aside
from central and IPVD, CKCS are also predisposed to primary secretory
otitis media, known to commonly be associated with peripheral VD.3,36
Springer spaniels were shown to have 3.37 times the odds of
diagnosis with VD compared to crossbreds. Springer Spaniels are pre-
disposed to cerebellar infarcts that occur most commonly within the
region supplied by the rostral cerebellar artery33 and to immune medi-
ated hemolytic anemia (IMHA)37 that is often associated with a hyper-
coagulable state. VD has been reported as a complication of IMHA.38
TABLE 4 Multivariable logistic regression results for variables that replaced breed in dogs with VD in the VetCompass database under
primary veterinary care in the United Kingdom from 1 January 2016 to 31 December 2016
Variable Category Odds ratio 95% CI P value
Purebred status Crossbred Base
Purebred 0.98 0.55-1.76 .97
Spaniel type breeds Nonspaniel type Base
Spaniel-type 1.98 1.61-2.43 <.001
Brachycephalic type breeds Nonbrachycephalic Base
Brachycephalic 1.29 1.02-1.63 .03
Adult (over 18 mo.) bodyweight (kg) 0-10 Base
10 to <25 2.26 1.78-2.87 <.001
25 to <40 2.21 1.69-2.89 <.001
≥40 2.13 1.30-3.50 .003
Unavailable 2.12 1.66-2.72 <.001
Age category (y) 0 to <3 Base
≥12 267.35 142.35-502.10 <.001
9 to <12 32.71 17.03-62.83 <.001
Unavailable 24.03 9.73-59.30 <.001
6 to <9 12.79 6.53-25.06 <.001
3 to <6 4.35 2.10-8.99 <.001
Abbreviation: VD, vestibular disease.
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TABLE 5 Description of vestibular disease cases in 759 dogs in the VetCompass database under primary veterinary care in the
United Kingdom from 1 January 2016 to 31 December 2016
Categories N (%)
Clinical signs Head tilt 530 (69.82)
Nystagmus 516 (67.98)
Ataxia 489 (64.42)
Collapse 244 (32.14)
Vomiting 195 (25.69)
Otitis externa 119 (15.67)
Central involvement 107 (14.09)
Treatments prescribed Antiemetics 328 (43.21)
Steroids 251 (33.06)
Antibiotics 190 (25.03)
Propentofylline 176 (23.18)
Intravenous fluid treatment 98 (12.91)
Nonsteroidal anti-inflammatories 75 (9.88)
Sedation 24 (3.16)
Antiemetic type Maropitant 302 (39.78)
Prochlorperazine 13 (1.71)
Metoclopramide 9 (1.18)
Maropitant + prochlorperazine 1 (0.13)
Maropitant + metoclopramide 1 (0.13)
Antimicrobial type Amoxicillin and clavulanic acid 108 (14.22)
Enrofloxacin 36 (4.74)
Marbofloxacin 11 (1.44)
Cefalexin 10 (1.31)
Cefovecin 6 (0.79)
Clindamycin 6 (0.79)
Pradofloxacin 6 (0.79)
Cefuroxime 4 (0.52)
Doxycycline 1 (0.13)
Metronidazole 1 (0.13)
Enrofloxacin + amoxiclav 1 (0.13)
Enrofloxacin + marbofloxacin 1 (0.13)
Sedative type Diazepam 13 (1.71)
Medetomidine 3 (0.39)
Midazolam 2 (0.26)
Hydroxyzine dihydrochloride 1 (0.13)
Diazepam + acepromazine 1 (0.13)
Outcomes Improvement recorded 316 (41.63)
Lost to follow-up 310 (40.84)
Death during the study period 232 (30.56)
Death due to vestibular disease during the
study period
144 (18.97)
Euthanasia at the same time with diagnosis 88 (11.59)
Recurrence 78 (10.27)
Definite diagnosis 35 (3.29)
Referred 27 (3.55)
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As expected, considering the breed predispositions, spaniel type
and brachycephalic type breeds were strongly associated with VD.
Dogs under 10 kg are substantially less likely to be affected by
VD compared with dogs of all other sizes. West Highland White, Jack
Russell, and Yorkshire Terries are all small breeds and are shown to
have decreased odds of VD in our study. Smaller breeds are known to
have increased longevity39 due to genetic factors that potentially con-
tribute to the lower risk of VD. Moreover, large breed dogs have an
increased oxidative damage and a faster rate of aging compared to
smaller breeds40 and this could potentially contribute to an increased
predisposition toward IPVD or other causes of VD.
In our study, the median age at first diagnosis was 12.68 years.
This suggests that IPVD might be implicated in most cases, as the
mean age of onset for IPVD in published literature is between 9.4 and
12.5 years.5,18,21 Other causes of VD cannot be excluded, however,
as it has been documented that the incidence of brain tumors, for
example, is higher in dogs older than 5 years.41 Regardless of the pri-
mary cause, VD should be considered a high-risk disease in older dogs,
especially in the predisposed breeds described above.
The most common clinical signs on presentation were ataxia, nys-
tagmus, and head tilt, which are clinical signs that are already known
as the hallmark signs of VD.42 Vertical nystagmus is generally present
only in central VD1,3 and was documented in 7.3% of the cases that
presented with nystagmus. This should be interpreted with caution
however, as vertical nystagmus can be difficult to differentiate from a
rotary one (which can be seen in either peripheral or central VD). The
presence of pathological nystagmus tends to be short-lived, especially
in cases of peripheral VD, because it can often be rapidly compen-
sated by voluntary visual fixation.3 The high prevalence of nystagmus
among the VD cases in our study therefore suggests an acute
presentation.
Vomiting is a common clinical sign of VD in dogs43 and in our
study 25.7% of cases presented with vomiting, similar to previously
published literature.18 Although vomiting occurs with VD regardless
of the cause, it is more common in dogs with acute peripheral VD and
is a result of the connection between the vestibular nuclei axons and
the vomiting center in the brainstem reticular formation.3,21 Vestibular
disorders in people are known to cause unpleasant autonomic signs
such as nausea and vomiting that can lead to anxiety and panic
attacks.44 Even though vomiting is usually transitory in dogs with
VD,21 it should therefore be considered to have welfare implications.
Collapse was recorded in 32.1% of the cases, but it is difficult to
discern whether this was due to central disease and loss of proprio-
ception or due to marked imbalance and disorientation. We therefore
suspect the presence of collapse is an indication of the severity of the
disease or the acute onset.
Differentiating between central and peripheral VD is an important
goal for the clinician when assessing a dog with signs of VD. Central
VD generally requires more expense to diagnose and treat, and can be
associated with a poorer prognosis.45 In our study, signs of central
involvement were identified in 14.1% of cases. However, the true pro-
portion with central VD could be higher as many cases did not have a
full neurological examination described in the EPRs.
Several disorders can cause peripheral VD but the most common
ones are IPVD and otitis media/interna.2 A study of 85 dogs with
peripheral VD referred for advanced imaging reported that 74% had
magnetic resonance imaging abnormalities7 but in our study only a
small percentage (3.6%) of the cases were referred. Otitis media is
diagnosed in 49% and 41% of peripheral VD cases7,18 although these
studies were both based on cases seen in specialist centers.
Otitis externa was recorded in 15.7% of the vestibular cases in
our study but it is possible that undiagnosed otitis externa was pre-
sent in further cases. Otitis media/interna is reported as the most
common cause of peripheral VD in dogs and is a common complica-
tion of otitis externa.3,46 A careful otoscopic examination should
therefore be performed when examining a dog with VD,47 even
though a normal tympanic membrane does not rule out the presence
of otitis media/interna.3
The presence of facial nerve paralysis or Horner's disease usually
indicates an underlying cause of peripheral vestibular dysfunction
such as otitis media/interna,48 therefore documenting these deficits
can help veterinary practitioners in differentiating between central
and peripheral VD. Moreover, cases with idiopathic facial nerve paral-
ysis can present with vestibular signs.34 In our study, 2/7 cases diag-
nosed with otitis media or interna had Horner's syndrome reported
(1 of which also had facial nerve palsy) and 3/14 cases diagnosed with
IPVD had facial nerve palsy reported.
Only 27 (3.6%) of the cases were referred. We suspect this is
related to the high rate of improvement noted in these cases, but
owner preference, financial constraints, age of the dog, guarded prog-
nosis, and veterinary recommendations might play a role. Either way,
this low proportional referral confirms that, for VD in dogs, studies
performed on referral caseloads will have limited generalizability to
the wider primary-care population because of selection bias and sug-
gest that epidemiological studies based on large primary-care
populations are needed to accurately benchmark primary-care clinical
activity.49
A formal cause of VD was recorded in only 32 (4.2%) cases. Most
of the cases that had either brain disease, IPVD, otitis media, or
interna confirmed were diagnosed in a referral center (19/32, 59%),
although some of the primary-care practices were capable of per-
forming advanced diagnostic imaging in-house in 13/32 (49%) of the
cases.
Because of the low proportion of referral and hence the limited
access to advanced imaging for diagnostic investigation, this limited
our ability to differentiate between the different causes of
VD. Consequently, the percentage of cases with vestibular signs cau-
sed by IPVD, for example, remains unknown. Since only a small per-
centage had signs of central involvement on presentation, it is likely
that most cases were characterized by peripheral vestibular dysfunc-
tion. This is contradictory to the findings based on referral populations
of VD cases, where 62% to 86% of the VD cases were diagnosed with
central VD,5,19 possibly because general practitioners might refer
more severe and central VD cases.
In our study, taking into consideration the signalment and presen-
tation of the vestibular cases as well as the significant rate of
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improvement, we suspected most cases were caused by IPVD. Clinical
signs associated with IPVD usually improve in 1 to 2 weeks and no
treatment has been proved beneficial.4,50
The most commonly used treatments for VD in our study were
antiemetics, systemic glucocorticoids, and antibiotics. Vomiting in
dogs with VD is similar to motion sickness and is present especially in
cases of acute vestibular dysfunction.1 Maropitant was the most com-
monly used antiemetic and it has been showed to be effective in the
prevention of vomiting induced by motion sickness in dogs.51
Systemic treatment with antimicrobials based on culture and sensi-
tivity is the medical treatment of choice for otitis media/interna.2 How-
ever, in our study, only 7 cases had otitis media/interna confirmed.
Moreover, only 15.7% of the cases had otitis externa documented and in
46.1% of the cases there was no mention of otoscopic examination.
Therefore, we suspected that many of the 25% cases that were pre-
scribed antibiotics were receiving these as an empirical treatment. From
the dogs treated with antibiotics, most received amoxicillin potentiated
with clavulanic acid (56.8%) although there is an important proportion of
cases (27.9%) that received fluoroquinolones. Compared to the most
commonly used antimicrobials in first opinion practice in the
United Kingdom, where fluoroquinolones were prescribed in 4.84% of
the cases that received antimicrobials,52 fluoroquinolones are used more
commonly in VD. The total use of antimicrobials classified as critically
important (CIAs) with highest priority for human medicine53 in VD cases
was 28.7% of the cases that received antimicrobial treatment, compared
to 6.4% in dogs that received antimicrobial treatment for all conditions in
primary care practices in United Kingdom in from 2012 to 2014.52
Similarly, although the use of systemic glucocorticoids is rec-
ommended in cases of inflammatory brain disease and possibly in
cases of otitis media/interna, it is likely that a large proportion of the
33.1% cases treated with glucocorticoids were treated empirically. In
cases of IPVD, there is no evidence that anti-inflammatory treatment
with glucocorticoids is beneficial.3 In addition, considering that gluco-
corticoids commonly cause adverse effects especially in older
dogs,54,55 glucocorticoid use should be limited to the cases with an
underlying cause where these treatments might be beneficial.
Improvement was recorded in 41.8% of the cases after a median
4 days but this ranged from 0 to 160 days from the first diagnosis. In
most cases that had a prolonged time to improvement documented,
this was likely because of delayed follow-up rather than slow
improvement. We therefore believe that the time to improvement
might be substantially shorter than reported here. Considering the
strict definition used for improvement and that in 40.7% of the cases
there was no mention of improvement or deterioration due to loss of
follow-up, we suspect the great majority of cases improved. A lack of
improvement was noted in only 16.4% of the cases.
A large number of cases (11.5%) were euthanized on presentation
and where VD contributed to the decision. This could be due to veter-
inary recommendations or at the request of the owner. VD cases can
show a dramatic presentation causing a lot of distress to the owners.
Also, considering that the median age at diagnosis was quite old, other
concurrent diseases could be contributing to the decision of euthana-
sia. However, it is possible that owners could now be reassured by
their veterinary surgeons about a good probability of improvement
reported in both the previous literature as well as the current study
and might opt to trial treatment which is generally affordable and to
monitor for signs of recovery for at least a few days after diagnosis in
a greater proportion of cases.
The limitations of the study mainly arise from the retrospective
design. The data collected from the EPRs were not recorded primarily
for research purposes and were therefore limited by incomplete infor-
mation and potential lack of accuracy. We suspect the prevalence of
8 per 10 000 dogs in our study is underreporting the prevalence of
VD in primary-care clinical practice. By using the search terms “nyst”
and “vest,” we retrieved 2600 potential cases and we manually evalu-
ated each against the case definition, but potential true cases could
have been missed due to misspelling or lack of complete entry of clini-
cal signs in the EPRs by the veterinary surgeon. Moreover, the case
definition for inclusion in the study relied on the veterinary surgeon
stating vestibular disease or a synonym but did not include other terms
commonly used by veterinary surgeons such as stroke, vascular acci-
dent, or similar. Using search terms like nyst to identify potential cases
likely introduced a bias toward the prevalence of nystagmus among
VD cases. The study included all cases of VD and did not attempt to
categorize these based on central/peripheral dysfunction or based on
etiology. A neurological examination was not recorded in most of the
cases, making the distinction between peripheral and central VD
impossible.
ACKNOWLEDGMENTS
The authors thank Noel Kennedy (RVC) for VetCompass software
and programming development. We acknowledge the Medivet Vet-
erinary Partnership, Vets4Pets/Companion Care, Goddard Veteri-
nary Group, Beaumont Sainsbury Animal Hospital, Independent
Vetcare, Linnaeus Group, CVS Group, PDSA, Vets Now, and the
other UK practices who collaborate in VetCompass. We are grateful
to The Kennel Club and The Kennel Club Charitable Trust for
supporting VetCompass.
CONFLICT OF INTEREST DECLARATION
Authors declare no conflict of interest.
OFF-LABEL ANTIMICROBIAL DECLARATION
Authors declare no off-label use of antimicrobials.
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE
(IACUC) OR OTHER APPROVAL DECLARATION
Royal Veterinary College Ethics and Welfare Committee (reference
number URN 2015 1369).
HUMAN ETHICS APPROVAL DECLARATION
Authors declare human ethics approval was not needed for this study.
ORCID
Sinziana Maria Radulescu https://orcid.org/0000-0002-7374-5949
Dan Gerard O'Neill https://orcid.org/0000-0003-1115-2723
10 RADULESCU ET AL.
REFERENCES
1. Sanders SG. Disorders of hearing and balance: the vestibulochochlear
nerve (CN VIII) and associated structures. In: Dewey CW, Costa RC,
eds. A Practical Guide to Canine and Feline Neurology. 3rd ed. Ames, IA:
Wiley-Blackwell; 2016:277-297.
2. Kent M, Platt SR, Schatzberg SJ. The neurology of balance: function
and dysfunction of the vestibular system in dogs and cats. Vet J.
2010;185(3):247-258.
3. Rossmeisl JH. Vestibular disease in dogs and cats. Vet Clin North Am
Small Anim Pract. 2010;40(1):81-100.
4. Garosi LS. Head tilt and nystagmus. In: Platt SR, Garosi LS, eds. Small
Animal Neurological Emergencies. London: Manson Publishing; 2012:
253-263.
5. Bongartz U, Nessler J, Maiolini A, Stein VM, Tipold A, Bathen-
Nöthen A. Vestibular disease in dogs: association between neurologi-
cal examination, MRI lesion localisation and outcome. J Small Anim
Pract. 2020;61(1):57-63.
6. Fluehmann G, Doherr MG, Jaggy A. Canine neurological diseases in a
referral hospital population between 1989 and 2000 in Switzerland.
J Small Anim Pract. 2006;47(10):582-587.
7. Garosi LS, Dennis R, Penderis J, et al. Results of magnetic resonance
imaging in dogs with vestibular disorders: 85 cases (1996-1999). J Am
Vet Med Assoc. 2001;218(3):385-391.
8. Bartlett PC, Van Buren JW, Neterer M, Zhou C. Disease surveillance
and referral bias in the veterinary medical database. Prev Vet Med.
2010;94(3–4):264-271.
9. O0Neill DG, Church DB, McGreevy PD, et al. Prevalence of disorders
recorded in dogs dttending primary-care veterinary practices in
England. PLoS One. 2014;9(3):e90501.
10. VeNom. The VeNom Coding Group [Internet]. VeNom Veterinary
Nomenclature [Online]. http://www.venomcoding.org/VeNom/
VeNom_Codes.html. Accessed November 27, 2018.
11. O'Neill DG, Scudder C, Faire JM, et al. Epidemiology of hyper-
adrenocorticism among 210,824 dogs attending primary-care veteri-
nary practices in the UK from 2009 to 2014. J Small Anim Pract.
2016;57(7):365-373.
12. Irion DN, Schaffer AL, Famula TR, Eggleston ML, Hughes SS,
Pedersen NC. Analysis of genetic variation in 28 dog breed
populations with 100 microsatellite markers. J Hered. 2003;94(1):
81-87.
13. Scott M, Flaherty D, Currall J. Statistics: how many? J Small Anim
Pract. 2012;53(7):372-376.
14. Breed Information Centre from the Kennel Club [Internet]. https://
www.thekennelclub.org.uk/services/public/breed/Default.aspx.
Accessed November 27, 2018.
15. Dohoo IR, Martin SW, Stryhn H. Veterinary Epidemiologic Research.
Charlotte, Canada: VER, Inc; 2009:865.
16. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. Hobo-
ken, NJ: John Wiley & Sons; 2004:392.
17. Troxel MT, Drobatz KJ, Vite CH. Signs of neurologic dysfunction in
dogs with central versus peripheral vestibular disease. J Am Vet Med
Assoc. 2005;227(4):570-574.
18. Schunk KL, Averill DR. Peripheral vestibular syndrome in the dog: a
review of 83 cases. J Am Vet Med Assoc. 1983;182(12):1354-1357.
19. Boudreau CE, Dominguez CE, Levine JM, et al. Reliability of interpre-
tation of neurologic examination findings for the localization of ves-
tibular dysfunction in dogs. J Am Vet Med Assoc. 2018;252(7):
830-838.
20. Mayousse V, Desquilbet L, Jeandel A, Blot S. Prevalence of neurologi-
cal disorders in French bulldog: a retrospective study of 343 cases
(2002–2016). BMC Vet Res. 2017;13(1):212.
21. Schunk KL. Disorders of the vestibular system. Vet Clin North Am
Small Anim Pract. 1988;18(3):641-665.
22. O'Neill DG, Jackson C, Guy JH, et al. Epidemiological associations
between brachycephaly and upper respiratory tract disorders in dogs
attending veterinary practices in England. Canine Genet Epidemiol.
2015;2(1):10.
23. O'Neill DG, Lee MM, Brodbelt DC, Church DB, Sanchez RF. Corneal
ulcerative disease in dogs under primary veterinary care in England:
epidemiology and clinical management. Canine Genet Epidemiol. 2017;
4(1):5.
24. O'Neill DG, Meeson RL, Sheridan A, Church DB, Brodbelt DC.
The epidemiology of patellar luxation in dogs attending primary-
care veterinary practices in England. Canine Genet Epidemiol. 2016;3
(1):4.
25. O'Neill DG, O'Sullivan AM, Manson EA, et al. Canine dystocia in
50 UK first-opinion emergency care veterinary practices: clinical man-
agement and outcomes. Vet Rec. 2019;184(13):409.
26. O'Neill DG, Baral L, Church DB, Brodbelt DC, Packer RMA. Demography
and disorders of the French Bulldog population under primary veterinary
care in the UK in 2013. Canine Genet Epidemiol. 2018;5(1):3.
27. Packer RMA, Hendricks A, Tivers MS, Burn CC. Impact of facial con-
formation on canine health: brachycephalic obstructive airway syn-
drome. PLoS One. 2015;10(10):e0137496.
28. O'Neill DG, Skipper AM, Kadhim J, Church DB, Brodbelt DC,
Packer RMA. Disorders of Bulldogs under primary veterinary care in
the UK in 2013. PLoS One. 2019;14(6):e0217928.
29. Summers JF, O'Neill DG, Church DB, Thomson PC, McGreevy PD,
Brodbelt DC. Prevalence of disorders recorded in Cavalier King
Charles Spaniels attending primary-care veterinary practices in
England. Canine Genet Epidemiol. 2015;2(1):4.
30. Rusbridge C. Neurological diseases of the Cavalier King Charles span-
iel. J Small Anim Pract. 2005;46(6):265-272.
31. Garosi L, McConnell JF, Platt SR, et al. Results of diagnostic investiga-
tions and long-term outcome of 33 dogs with brain infarction
(2000-2004). J Vet Intern Med. 2005;19(5):725-731.
32. Thomsen B, Garosi L, Skerritt G, et al. Neurological signs in 23 dogs
with suspected rostral cerebellar ischaemic stroke. Acta Vet Scand.
2016;58(1):40.
33. McConnell JF, Garosi L, Platt SR. Magnetic resonance imaging find-
ings of presumed cerebellar cerebrovascular accident in twelve dogs.
Vet Radiol Ultrasound. 2005;46(1):1-10.
34. Chan MK, Toribio JALML, Podadera JM, Child G. Incidence, cause,
outcome and possible risk factors associated with facial nerve paraly-
sis in dogs in a Sydney population (2001–2016): a retrospective
study. Aust Vet J. 2020;98(4):140-147.
35. Jeandel A, Thibaud JL, Blot S. Facial and vestibular neuropathy of
unknown origin in 16 dogs. J Small Anim Pract. 2016;57(2):74-78.
36. Cole LK. Primary secretory otitis media in Cavalier King Charles span-
iels. Vet Clin North Am Small Anim Pract. 2012;42(6):1137-1142.
37. McAlees T. Immune-mediated haemolytic anaemia in 110 dogs in Vic-
toria, Australia. Aust Vet J. 2010;88(1-2):25-28.
38. West LD, Hart JR. Treatment of idiopathic immune-mediated hemo-
lytic anemia with mycophenolate mofetil in five dogs. J Vet Emerg Crit
Care. 2014;24(2):226-231.
39. O'Neill DG, Church DB, McGreevy PD, et al. Longevity and mortality
of owned dogs in England. Vet J. 2013;198(3):638-643.
40. Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. The effect of
breed on age-related changes in behavior and disease prevalence in
cognitively normal older community dogs, Canis lupus familiaris. J Vet
Behav. 2012;7(2):61-69.
41. Bagley RS, Gavin PR, Moore MP, Silver GM, Harrington ML,
Connors RL. Clinical signs associated with brain tumors in dogs:
97 cases (1992-1997). J Am Vet Med Assoc. 1999;215(6):818-819.
42. Lorenz MD, Coates JR, Kent M. Handbook of Veterinary Neurology. St.
Louis, MO: Elsevier/Saunders; 2011:545.
43. Thomas WB. Vestibular dysfunction. Vet Clin North Am Small Anim
Pract. 2000;30(1):227-249.
44. Brandt T. Management of vestibular disorders. J Neurol. 2000;247(7):
491-499.
RADULESCU ET AL. 11
45. Lowrie M, Vetmb M. Vestibular disease: anatomy, physiology, and
clinical signs. Compend Contin Educ Vet. 2012;34(7):E1.
46. Lowrie M, Vetmb MA. Vestibular disease: diseases causing vestibular
signs. Compend Contin Educ Vet. 2012;34(7):E2.
47. Platt SR, Jaggy A. Small Animal Neurology: An Illustrated Text. Hanno-
ver: Schlütersche; 2010:580.
48. Garosi LS, Lowrie ML, Swinbourne NF. Neurological manifestations
of ear disease in dogs and cats. Vet Clin North Am Small Anim Pract.
2012;42(6):1143-1160.
49. O'Neill DG, Church DB, McGreevy PD, et al. Approaches to canine
health surveillance. Canine Genet Epidemiol. 2014;1(1):2.
50. Bagley RS. Common neurological disease of older animals. Vet Clin
North Am Small Anim Pract. 1997;18:731-742.
51. Conder GA, Sedlacek HS, Boucher JF, Clemence RG. Efficacy and
safety of maropitant, a selective neurokinin 1 receptor antagonist, in
2 randomized clinical trials for prevention of vomiting due to motion
sickness in dogs. J Vet Pharmacol Ther. 2008;31(6):528-532.
52. Buckland EL, O'Neill D, Summers J, et al. Characterisation of antimi-
crobial usage in cats and dogs attending UK primary care companion
animal veterinary practices. Vet Rec. 2016;179(19):489.
53. Who [Internet]. Critically Important Antimicrobials for Human Medicine,
5th revision. 2017. https://www.who.int/foodsafety/publications/
antimicrobials-fifth/en/. Accessed October 16, 2019.
54. Masters AK, Berger DJ, Ware WA, et al. Effects of short-term anti-
inflammatory glucocorticoid treatment on clinicopathologic, echocar-
diographic, and hemodynamic variables in systemically healhty dogs.
Am J Vet Res. 2018;79(4):411-423.
55. Tinklenberg RL, Murphy SD, Mochel JP, et al. Evaluation of dose-
response effects of short-term oral prednisone administration on clin-
icopathologic and hemodynamic variables in healthy dogs. Am J Vet
Res. 2020;81(4):317-325.
How to cite this article: Radulescu SM, Humm K,
Eramanis LM, et al. Vestibular disease in dogs under UK
primary veterinary care: Epidemiology and clinical
management. J Vet Intern Med. 2020;1–12. https://doi.org/10.
1111/jvim.15869
12 RADULESCU ET AL.
